Titre:
  • p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
Auteur:Sonnenblick, Amir; Salgado, Roberto; Brohée, Sylvain; Zahavi, Tamar; Peretz, Tamar; Van den Eynden, Gert; Rouas, Ghizlane; Salmon, Asher; Francis, Prudence A; Di Leo, Angelo; Crown, John P A; Viale, Giuseppe; Daly, Laura; Javdan, Bahar; Fujisawa, Sho; De Azambuja, Evandro; Ameye, Lieveke; Piccart-Gebhart, Martine; Bromberg, Jacqueline F; Sotiriou, Christos
Informations sur la publication:International journal of oncology, 52, 2, page (424-432)
Statut de publication:Publié, 2018
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Mots-clés:Adjuvant
Breast cancer
Chemotherapy
Estrogen receptor
Luminal cancer
Prognostic marker
Signal transducer and activator of transcription 3
Tyrosine phosphorylation
MeSH keywords:Adenocarcinoma -- drug therapy -- mortality
Aged
Anthracyclines -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Biomarkers, Tumor -- analysis
Breast Neoplasms -- drug therapy -- mortality
Chemotherapy, Adjuvant -- methods
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Phosphorylation
Prognosis
Receptors, Estrogen -- metabolism
STAT3 Transcription Factor -- biosynthesis
Taxoids -- therapeutic use
Transcriptome
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1019-6439
info:doi/10.3892/ijo.2017.4212
info:scp/85040314897
info:pmid/29207087